Innovative treatment option

Nov. 1, 1998
Block Drug Corporation has approval to use Atridox™ (10.0% doxycycline hyclate) in the ATRIGEL® delivery system for the treatment of periodontal disease. Atridox™ offers a new treatment option that is both effective and comfortable for the millions of Americans plagued with infected, inflamed gums associated with periodontal disease.

Block Drug Corporation has approval to use Atridox™ (10.0% doxycycline hyclate) in the ATRIGEL® delivery system for the treatment of periodontal disease. Atridox™ offers a new treatment option that is both effective and comfortable for the millions of Americans plagued with infected, inflamed gums associated with periodontal disease.

- Atridox™ combines the antibiotic doxycycline with a unique gel that the dentist applies to periodontal pockets to fight the bacteria that cause this chronic infection in adults. Atridox™ continuously releases the antibiotic over seven days to safely fight the periodontal infection.